Skip to content

A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane

Dwight I. Peretz, John Smythies, William C. Gibson

Journal of Mental Science April 1, 1955 DOI: 10.1192/bjp.101.423.317 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Interventions 3 4 5-Trimethoxyphenyl-β-aminopropane (TMA)
Topics Mescaline
Keywords Hallucinogen Amphetamine
Citations 55
Key findings TMA is structurally related to both amphetamine and mescaline, raising the question of whether its clinical effects would combine characteristics of both drugs.

Abstract

3,4,5-Trimethoxyphenyl-β-aminopropane (TMA) is structurally related to both amphetamine and mescaline, as is shown in Figure 1. Because of this structural relationship of TMA and amphetamine, methedrine, and mescaline, one could anticipate a clinical response to the compound which would represent certain phenomena characteristic of each of these drugs. This presented an intriguing problem as to whether or not, in actuality, this would be the case.

Comparable studies

Other case reports and case series on mescaline, most cited first.

Study Year Design Participants
Parkinsonism after Taking Ecstasy 29-year-old man 1999 Case study n = 1
Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology A patient with methylenedioxyamphetamine intoxication 1981 Case study n = 1
Peyote and mescaline exposures: a 12-year review of a statewide poison center database Patients who used peyote or mescaline and required treatment 2010 Case series
A Mescaline Associated Fatality A single deceased individual under the influence of mescaline 1985 Case study n = 1
"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES Two teenage boys with maladjusted and impulsive personalities 1964 Case study n = 2

Citations in the library

Explore topics